health · HHS-NIH11
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
National Institutes of Health · PAR-27-026
Deadline
September 25, 2028
GRANTQUICK SUMMARYPlain-English Overview
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional). National Institutes of Health. The purpose of this notice of funding opportunity (NOFO) is to support innovative basic, clinical, translational, and implementation science research relevant to HIV and substance use. This initiative encourages high risk high impact transformative studies that advance knowledge and strategies for... Funding amounts not specified.
Who Should Apply
Other Native American Tribal Organizations, City/township governments, Federally Recognized Native American Tribal Governments, Private universities/colleges, Public And Indian Housing Authorities (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Refer to Section III
- •Deadline: 2028-09-25
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
nidagmbemail@nida.nih.gov nidagmbemail@nida.nih.gov
nidagmbemail@nida.nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov